Early Immunotherapy with Intravenous Immunoglobulin, Cyclophosphamide and Methylprednisolone in Patients with Anti-Hu-associated Paraneoplastic Sensory Neuronopathy

NCT06373211 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Paraneoplastic Sensory Neuronopathy

Interventions

DRUG: Immunoglobulins IV (CLAYRIG)
DRUG: Cyclophosphamide IV
DRUG: Methylprednisolone IV

Sponsor

Assistance Publique - Hôpitaux de Paris